{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:15Z","timestamp":1792787895112,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Bal\u0131kesir University Scientific Research Projects Unit","award":["2025\/045"],"award-info":[{"award-number":["2025\/045"]}],"id":[{"id":"https:\/\/ror.org\/02tv7db43","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02507-4","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:28:13Z","timestamp":1787228893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic and hormonal correlates of leptin, uric acid and soluble neprilysin in polycystic ovary syndrome\/ Polyendocrine Metabolic Ovarian Syndrome"],"prefix":"10.1186","volume":"26","author":[{"given":"Bayram Burak","family":"Ceviz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Baykan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1790-7963","authenticated-orcid":false,"given":"Figen","family":"Efe Camili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"Islimye Taskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orkun","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"1","key":"2507_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s12905-025-03976-w","volume":"25","author":"O Chai","year":"2025","unstructured":"Chai O, Feng X, Tang N, et al. Global and regional burden of polycystic ovary syndrome, 1990\u20132021: a systematic analysis of the global burden of disease study 2021. BMC Womens Health. 2025;25(1):437. https:\/\/doi.org\/10.1186\/s12905-025-03976-w.","journal-title":"BMC Womens Health"},{"issue":"4","key":"2507_CR2","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/humrep\/deaa371","volume":"36","author":"J Liu","year":"2021","unstructured":"Liu J, Wu Q, Hao Y, et al. Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017. Hum Reprod. 2021;36(4):1108\u201319. https:\/\/doi.org\/10.1093\/humrep\/deaa371.","journal-title":"Hum Reprod"},{"key":"2507_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.coemr.2020.02.013","volume":"12","author":"DA Dumesic","year":"2020","unstructured":"Dumesic DA, Abbott DH, Sanchita S, Chazenbalk GD. Endocrine-Metabolic Dysfunction in Polycystic Ovary Syndrome: an Evolutionary Perspective. Curr Opin Endocr Metab Res. 2020;12:41\u20138. https:\/\/doi.org\/10.1016\/j.coemr.2020.02.013.","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"1","key":"2507_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13048-025-01621-6","volume":"18","author":"P Su","year":"2025","unstructured":"Su P, Chen C, Sun Y. Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation. J Ovarian Res. 2025;18(1):34. https:\/\/doi.org\/10.1186\/s13048-025-01621-6.","journal-title":"J Ovarian Res"},{"issue":"4","key":"2507_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","volume":"21","author":"N Helvaci","year":"2025","unstructured":"Helvaci N, Yildiz BO. Polycystic ovary syndrome as a metabolic disease. Nat Rev Endocrinol. 2025;21(4):230\u201344. https:\/\/doi.org\/10.1038\/s41574-024-01057-w.","journal-title":"Nat Rev Endocrinol"},{"key":"2507_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(26)00717-8","author":"HJ Teede","year":"2026","unstructured":"Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026. https:\/\/doi.org\/10.1016\/S0140-6736(26)00717-8.","journal-title":"Lancet"},{"issue":"3","key":"2507_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/rjpm2030037","volume":"2","author":"S-E C\u00eerstoiu","year":"2023","unstructured":"C\u00eerstoiu S-E, Mehedin\u021bu C. Screening and Diagnosis of Polycystic Ovary Syndrome Corelated with Evidence-Based International Guidelines 2023 Recommendations. Romanian J Prev Med. 2023;2(3):37\u201343. https:\/\/doi.org\/10.3390\/rjpm2030037.","journal-title":"Romanian J Prev Med"},{"issue":"10","key":"2507_CR8","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","volume":"108","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJE, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447\u201369. https:\/\/doi.org\/10.1210\/clinem\/dgad463.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2507_CR9","doi-asserted-by":"publisher","first-page":"e2298","DOI":"10.1210\/clinem\/dgae910","volume":"110","author":"AE Joham","year":"2025","unstructured":"Joham AE, Tay CT, Laven J, Louwers YV, Azziz R. Approach to the Patient: Diagnostic Challenges in the Workup for Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2025;110(7):e2298\u2013308. https:\/\/doi.org\/10.1210\/clinem\/dgae910.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2507_CR10","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/jcm12041454","volume":"12","author":"S Singh","year":"2023","unstructured":"Singh S, Pal N, Shubham S, et al. Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics. J Clin Med. 2023;12(4):1454. https:\/\/doi.org\/10.3390\/jcm12041454.","journal-title":"J Clin Med"},{"issue":"12","key":"2507_CR11","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1080\/09513590.2021.1942452","volume":"37","author":"Y Wang","year":"2021","unstructured":"Wang Y, Ni Z, Li K. The prevalence of anxiety and depression of different severity in women with polycystic ovary syndrome: a meta-analysis. Gynecol Endocrinol. 2021;37(12):1072\u20138. https:\/\/doi.org\/10.1080\/09513590.2021.1942452.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"2507_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s13668-023-00479-8","volume":"12","author":"M Di Lorenzo","year":"2023","unstructured":"Di Lorenzo M, Cacciapuoti N, Lonardo MS, et al. Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review. Curr Nutr Rep. 2023;12(3):527\u201344. https:\/\/doi.org\/10.1007\/s13668-023-00479-8.","journal-title":"Curr Nutr Rep"},{"key":"2507_CR13","doi-asserted-by":"publisher","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35:100937. https:\/\/doi.org\/10.1016\/j.molmet.2020.01.001.","journal-title":"Mol Metab"},{"key":"2507_CR14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2020","unstructured":"Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214\u201321. https:\/\/doi.org\/10.1016\/j.cca.2019.11.003.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"2507_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/humupd\/dmy007","volume":"24","author":"NS Kakoly","year":"2018","unstructured":"Kakoly NS, Khomami MB, Joham AE, et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum Reprod Update. 2018;24(4):455\u201367. https:\/\/doi.org\/10.1093\/humupd\/dmy007.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2507_CR16","doi-asserted-by":"publisher","first-page":"e250226","DOI":"10.1530\/JOE-25-0226","volume":"267","author":"YC Ma","year":"2025","unstructured":"Ma YC, Law KS, Wang WS, Chang HM. Phenotypic variations in polycystic ovary syndrome: metabolic risks and emerging biomarkers. J Endocrinol. 2025;267(1):e250226. https:\/\/doi.org\/10.1530\/JOE-25-0226.","journal-title":"J Endocrinol"},{"issue":"5 Pt 2","key":"2507_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.fertnstert.2025.08.033","volume":"124","author":"I Lee","year":"2025","unstructured":"Lee I, Dokras A, Alur-Gupta S. Association of polycystic ovary syndrome with atherosclerotic cardiovascular disease events. Fertil Steril. 2025;124(5 Pt 2):919\u201330. https:\/\/doi.org\/10.1016\/j.fertnstert.2025.08.033.","journal-title":"Fertil Steril"},{"key":"2507_CR18","doi-asserted-by":"publisher","first-page":"585887","DOI":"10.3389\/fendo.2021.585887","volume":"12","author":"M Obradovic","year":"2021","unstructured":"Obradovic M, Sudar-Milovanovic E, Soskic S, et al. Leptin and Obesity: Role and Clinical Implication. Front Endocrinol (Lausanne). 2021;12:585887. https:\/\/doi.org\/10.3389\/fendo.2021.585887.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2507_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.23736\/S2724-606X.22.05139-9","volume":"75","author":"K Nikolettos","year":"2023","unstructured":"Nikolettos K, Nikolettos N, Vlahos N, Pagonopoulou O, Asimakopoulos B. Role of leptin, adiponectin, and kisspeptin in polycystic ovarian syndrome pathogenesis. Minerva Obstet Gynecol. 2023;75(5):460\u20137. https:\/\/doi.org\/10.23736\/S2724-606X.22.05139-9.","journal-title":"Minerva Obstet Gynecol"},{"key":"2507_CR20","doi-asserted-by":"publisher","first-page":"1475465","DOI":"10.3389\/fendo.2025.1475465","volume":"16","author":"D Orszulak","year":"2025","unstructured":"Orszulak D, Nizi\u0144ski K, Maton\u00f3g A, Zi\u0119ba-Domalik M, Stojko R, Drosdzol-Cop A. Adipokines as biochemical marker of polycystic ovary syndrome in adolescents - review. Front Endocrinol (Lausanne). 2025;16:1475465. https:\/\/doi.org\/10.3389\/fendo.2025.1475465.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2507_CR21","doi-asserted-by":"publisher","first-page":"120425","DOI":"10.1016\/j.cca.2025.120425","volume":"576","author":"I Singh","year":"2025","unstructured":"Singh I, Moar K, Maurya PK. Diagnostic and prognostic biomarkers in Polycystic Ovary Syndrome. Clin Chim Acta. 2025;576:120425. https:\/\/doi.org\/10.1016\/j.cca.2025.120425.","journal-title":"Clin Chim Acta"},{"key":"2507_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40885-020-00146-y","volume":"26","author":"SJ Lee","year":"2020","unstructured":"Lee SJ, Oh BK, Sung KC. Uric acid and cardiometabolic diseases. Clin Hypertens. 2020;26:13. https:\/\/doi.org\/10.1186\/s40885-020-00146-y.","journal-title":"Clin Hypertens"},{"issue":"4","key":"2507_CR23","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.metabol.2015.11.003","volume":"65","author":"TY Yu","year":"2016","unstructured":"Yu TY, Jee JH, Bae JC, et al. Serum uric acid: A strong and independent predictor of metabolic syndrome after adjusting for body composition. Metabolism. 2016;65(4):432\u201340. https:\/\/doi.org\/10.1016\/j.metabol.2015.11.003.","journal-title":"Metabolism"},{"issue":"3","key":"2507_CR24","doi-asserted-by":"publisher","first-page":"e0388","DOI":"10.1097\/HPC.0000000000000388","volume":"24","author":"A Shubietah","year":"2025","unstructured":"Shubietah A, Awashra A, Milhem F, et al. Hyperuricemia and Cardiovascular Risk: Insights and Implications. Crit Pathw Cardiol. 2025;24(3):e0388. https:\/\/doi.org\/10.1097\/HPC.0000000000000388.","journal-title":"Crit Pathw Cardiol"},{"issue":"1","key":"2507_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12958-021-00748-7","volume":"19","author":"J Hu","year":"2021","unstructured":"Hu J, Xu W, Yang H, Mu L. Uric acid participating in female reproductive disorders: a review. Reprod Biol Endocrinol. 2021;19(1):65. https:\/\/doi.org\/10.1186\/s12958-021-00748-7.","journal-title":"Reprod Biol Endocrinol"},{"key":"2507_CR26","doi-asserted-by":"publisher","first-page":"1356859","DOI":"10.3389\/fendo.2024.1356859","volume":"15","author":"Z Gong","year":"2024","unstructured":"Gong Z, Sun Y, Zhang L, Zhu X, Shi Y. The positive association between hyperuricemia and polycystic ovary syndrome and analysis of related factors. Front Endocrinol. 2024;15:1356859. https:\/\/doi.org\/10.3389\/fendo.2024.1356859.","journal-title":"Front Endocrinol"},{"issue":"6","key":"2507_CR27","doi-asserted-by":"publisher","first-page":"856","DOI":"10.25259\/IJMR_1903_2025","volume":"162","author":"C Akkus","year":"2025","unstructured":"Akkus C, Oner O, Okan Kilic A, Ucar Toros M, Duran C. Serum uric acid levels in patients with different phenotypes of polycystic ovary syndrome. Indian J Med Res. 2025;162(6):856\u201362. https:\/\/doi.org\/10.25259\/IJMR_1903_2025.","journal-title":"Indian J Med Res"},{"issue":"11","key":"2507_CR28","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1093\/humrep\/deae219","volume":"39","author":"D Feng","year":"2024","unstructured":"Feng D, Wang X, Song J, et al. Association of uric acid and fructose levels in polycystic ovary syndrome. Hum Reprod. 2024;39(11):2575\u201386. https:\/\/doi.org\/10.1093\/humrep\/deae219.","journal-title":"Hum Reprod"},{"key":"2507_CR29","doi-asserted-by":"publisher","first-page":"111363","DOI":"10.1016\/j.mad.2020.111363","volume":"192","author":"NN Nalivaeva","year":"2020","unstructured":"Nalivaeva NN, Zhuravin IA, Turner AJ. Neprilysin expression and functions in development, ageing and disease. Mech Ageing Dev. 2020;192:111363. https:\/\/doi.org\/10.1016\/j.mad.2020.111363.","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"2507_CR30","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1038\/s41598-021-85490-1","volume":"11","author":"J N\u00fa\u00f1ez","year":"2021","unstructured":"N\u00fa\u00f1ez J, N\u00fa\u00f1ez E, Revuelta-L\u00f3pez E, et al. The influence of sex and body mass index on the association between soluble neprilysin and risk of heart failure hospitalizations. Sci Rep. 2021;11(1):5940. https:\/\/doi.org\/10.1038\/s41598-021-85490-1.","journal-title":"Sci Rep"},{"issue":"1","key":"2507_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ihj.2020.01.006","volume":"72","author":"K Ramanathan","year":"2020","unstructured":"Ramanathan K, Padmanabhan G. Soluble neprilysin: A versatile biomarker for heart failure, cardiovascular diseases and diabetic complications-A systematic review. Indian Heart J. 2020;72(1):14\u20139. https:\/\/doi.org\/10.1016\/j.ihj.2020.01.006.","journal-title":"Indian Heart J"},{"issue":"8","key":"2507_CR32","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.3390\/diagnostics12081922","volume":"12","author":"PM Spritzer","year":"2022","unstructured":"Spritzer PM, Marchesan LB, Santos BR, Fighera TM, Hirsutism. Normal Androgens and Diagnosis of PCOS. Diagnostics (Basel). 2022;12(8):1922. https:\/\/doi.org\/10.3390\/diagnostics12081922.","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"2507_CR33","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/cen.14421","volume":"95","author":"TM Barber","year":"2021","unstructured":"Barber TM, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf). 2021;95(4):531\u201341. https:\/\/doi.org\/10.1111\/cen.14421.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2507_CR34","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/medicina61030424","volume":"61","author":"B Keyif","year":"2025","unstructured":"Keyif B, Yavuzcan A. Visceral and Dysfunctional Adiposity Indices as Predictors of Insulin Resistance and Metabolic Syndrome in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study. Med (Kaunas). 2025;61(3):424. https:\/\/doi.org\/10.3390\/medicina61030424.","journal-title":"Med (Kaunas)"},{"issue":"4","key":"2507_CR35","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.rbmo.2018.08.007","volume":"37","author":"L Mu","year":"2018","unstructured":"Mu L, Zhao Y, Li R, Lai Y, Qiao J. Metabolic characteristics of normal weight central obesity phenotype polycystic ovary syndrome women: a large-scale national epidemiological survey. Reprod Biomed Online. 2018;37(4):498\u2013504. https:\/\/doi.org\/10.1016\/j.rbmo.2018.08.007.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"2507_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/biomedicines12020355","volume":"12","author":"FE Camili","year":"2024","unstructured":"Camili FE, Akis M, Adali E, et al. Oncostatin M Is Related to Polycystic Ovary Syndrome-Case Control Study. Biomedicines. 2024;12(2):355. https:\/\/doi.org\/10.3390\/biomedicines12020355.","journal-title":"Biomedicines"},{"issue":"15","key":"2507_CR37","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.3390\/ijms20153778","volume":"20","author":"A Bongrani","year":"2019","unstructured":"Bongrani A, Mellouk N, Rame C, et al. Ovarian Expression of Adipokines in Polycystic Ovary Syndrome: A Role for Chemerin, Omentin, and Apelin in Follicular Growth Arrest and Ovulatory Dysfunction? Int J Mol Sci. 2019;20(15):3778. https:\/\/doi.org\/10.3390\/ijms20153778.","journal-title":"Int J Mol Sci"},{"key":"2507_CR38","doi-asserted-by":"publisher","first-page":"881684","DOI":"10.3389\/fendo.2022.881684","volume":"13","author":"P Chen","year":"2022","unstructured":"Chen P, Jia R, Liu Y, Cao M, Zhou L, Zhao Z. Progress of Adipokines in the Female Reproductive System: A Focus on Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2022;13:881684. https:\/\/doi.org\/10.3389\/fendo.2022.881684.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2507_CR39","doi-asserted-by":"publisher","first-page":"105852","DOI":"10.1016\/j.jsbmb.2021.105852","volume":"209","author":"S Nikanfar","year":"2021","unstructured":"Nikanfar S, Oghbaei H, Rastgar Rezaei Y, et al. Role of adipokines in the ovarian function: Oogenesis and steroidogenesis. J Steroid Biochem Mol Biol. 2021;209:105852. https:\/\/doi.org\/10.1016\/j.jsbmb.2021.105852.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"2507_CR40","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.3390\/ijms23063188","volume":"23","author":"ME Gherghina","year":"2022","unstructured":"Gherghina ME, Peride I, Tiglis M, Neagu TP, Niculae A, Checherita IA. Uric Acid and Oxidative Stress-Relationship with Cardiovascular, Metabolic, and Renal Impairment. Int J Mol Sci. 2022;23(6):3188. https:\/\/doi.org\/10.3390\/ijms23063188.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2507_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4183\/aeb.2022.35","volume":"18","author":"OO Gul","year":"2022","unstructured":"Gul OO, Sisman P, Cander S, Sarandol E, Ersoy C, Erturk E. Plasma Neprilysin Levels in Patients with Polycystic Ovary Syndrome. Acta Endocrinol (Buchar). 2022;18(1):35\u20139. https:\/\/doi.org\/10.4183\/aeb.2022.35.","journal-title":"Acta Endocrinol (Buchar)"},{"key":"2507_CR42","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/ijo.2010.227","volume":"35","author":"K Standeven","year":"2011","unstructured":"Standeven K, Hess K, Carter A, et al. Neprilysin, obesity and the metabolic syndrome. Int J Obes. 2011;35:1031\u201340. https:\/\/doi.org\/10.1038\/ijo.2010.227.","journal-title":"Int J Obes"},{"key":"2507_CR43","doi-asserted-by":"publisher","first-page":"8005","DOI":"10.3390\/app13148005","volume":"13","author":"M Sperling","year":"2023","unstructured":"Sperling M, Grzelak T, Pelczy\u0144ska M, Bogda\u0144ski P, Czy\u017cewska K, Formanowicz D, Adipolin. Chemerin, Neprilysin and Metabolic Disorders Associated with Obesity. Appl Sci. 2023;13:8005. https:\/\/doi.org\/10.3390\/app13148005.","journal-title":"Appl Sci"},{"key":"2507_CR44","doi-asserted-by":"publisher","unstructured":"Iliodromiti S, Kelsey TW, Anderson RA, Nelson SM. Can anti-M\u00fcllerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab. 2013;98(8):3332\u20133340. https:\/\/doi.org\/10.1210\/jc.2013-1393.","DOI":"10.1210\/jc.2013-1393"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02507-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02507-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02507-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:03:47Z","timestamp":1790633027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02507-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2507"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02507-4","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"28 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Clinical Research Ethics Committee of the Faculty of Medicine at Bal\u0131kesir University (Ethics Committee Approval No: 2025\/247). The study was conducted in accordance with the principles of the Declaration of Helsinki and adhered to the ethical standards of the country in which the research was carried out. Informed consent was obtained from all subjects involved in the study.","order":1,"name":"Ethics","label":"Ethics approval and informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"288"}}